[1]马娟 范洁.无导线起搏器与传统起搏器并发症比较[J].心血管病学进展,2022,(9):819-823.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
　MA Juan,FAN Jie.Comparison of Complications Between Leadless Cardiac Pacemaker and Traditional Pacemaker[J].Advances in Cardiovascular Diseases,2022,(9):819-823.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
点击复制

无导线起搏器与传统起搏器并发症比较()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年9期
页码:
819-823
栏目:
出版日期:
2022-09-25

文章信息/Info

Title:
Comparison of Complications Between Leadless Cardiac Pacemaker and Traditional Pacemaker
作者:
马娟1 范洁 1; 2
(1.昆明理工大学医学院,云南 昆明 650100;2. 云南省第一人民医院心血管内科,云南 昆明 650100)
Author(s):
MA Juan1;  FAN Jie1; 2
(1. School of Medicine,Kunming University of Science and Technology,Kunming 650100,Yunnan,China; 2. Department of Cardiology,The First Peoples Hospital of Yunnan Province,Kunming 650100,Yunnan,China)
关键词:
传统起搏器; 无导线起搏器; 并发症
Keywords:
Traditional pacemaker; Leadless cardiac pacemaker; Complication
DOI:
10.16806/j.cnki.issn.1004-3934.2022.09.013
摘要:
传统起搏器的囊袋和起搏导线引起的相关并发症一直是临床应用中无法回避的问题，针对传统起搏器的上述不足，无导线起搏器随之诞生，并在心脏起搏领域取得了很大进展。尽管目前无导线起搏器已在临床上应用了一段时间，但其并发症及安全性仍备受关注。现综述无导线起搏器和传统起搏器并发症的发生情况，以评估无导线起搏器与传统起搏器相比在减少并发症方面是否更具优势。
Abstract:
The related complications caused by the pocket and lead of the traditional pacemaker have always been an unavoidable problem in its clinical application. In view of the above shortcomings of traditional pacemaker,leadless cardiac pacemaker was born and made great progress in the field of cardiac pacing. Although leadless cardiac pacemaker has been used in clinic for a period of time,its complications and safety are still concerned. This article reviews the complications of leadless cardiac pacemaker and traditional pacemaker to evaluate whether leadless cardiac pacemaker has more advantages in reducing complications than traditional pacemaker.

参考文献/References:

[1] Eberhardt F,Bode F,Bonnemeier H,et al. Long term complications in single and dual chamber pacing are influenced by surgical experience and patient morbidity[J]. Heart,2005,91(4):500-506.

[2] Larsson B,Elmqvist H,Ryden L,et al. Lessons from the first patient with an implanted pacemaker:1958–2001[J]. Pacing Clin Electrophysiol,2003,26(1 Pt 1):114-124.

[3] El-Chami MF,Merchant FM,Leon AR. Leadless pacemakers[J]. Am J Cardiol,2017,119(1):145-148.

[4] Kirkfeldt RE,Johansen JB,Nohr EA,et al. Complications after cardiac implantable electronic device implantations:an analysis of a complete,nationwide cohort in Denmark[J]. Eur Heart J,2014,35(18):1186-1194.

[5] Udo EO,Zuithoff NPA,van Hemel NM,et al. Incidence and predictors of short- and long-term complications in pacemaker therapy:the FOLLOWPACE study[J]. Heart Rhythm,2012,9(5):728-735.

[6] Reynolds D,Duray GZ,Omar R,et al. A leadless intracardiac transcatheter pacing system[J]. N Engl J Med,2016,374(6):533-541.

[7] Piccini JP,El-Chami M,Wherry K,et al. Contemporaneous comparison of outcomes among patients implanted with a leadless vs transvenous single-chamber ventricular pacemaker[J]. JAMA Cardiol,2021,6(10):1187-1195.

[8] Roberts PR,Clementy N,Al Samadi F,et al. A leadless pacemaker in the real-world setting:the Micra Transcatheter Pacing System Post-Approval Registry[J]. Heart Rhythm,2017,14(9):1375-1379.

[9] Vaidya VR,Dai M,Asirvatham SJ,et al. Real‐world experience with leadless cardiac pacing[J]. Pacing Clin Electrophysiol,2019,42(3):366-373.

[10] Tjong FVY, Knops RE,Udo EO,et al. Leadless pacemaker versus transvenous single-chamber pacemaker therapy:a propensity score-matched analysis[J]. Heart Rhythm,2018,15(9):1387-1393.

[11] Res JC,de Priester JA,van Lier AA,et al. Pneumothorax resulting from subclavian puncture:a complication of permanent pacemaker lead implantation[J]. Neth Heart J,2004,12(3):101-105.

[12] 梁静,史冬梅,李月平,等. 无导线起搏器与传统单腔起搏器临床应用的对比分析[J]. 心肺血管病杂志,2021,40(5):401-405.

[13] Moore SKL,Chau KH,Chaudhary S,et al. Leadless pacemaker implantation:a feasible and reasonable option in transcatheter heart valve replacement patients[J]. Pacing Clin Electrophysiol,2019,42(5):542-547.

[14] El-Chami MF,Al-Samadi F,Clementy N,et al. Updated performance of the Micra transcatheter pacemaker in the real-world setting:a comparison to the investigational study and a transvenous historical control[J]. Heart Rhythm,2018,15(12):1800-1807.

[15] Cantillon DJ,Dukkipati SR,Ip JH,et al. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers[J]. Heart Rhythm,2018,15(7):1023-1030.

[16] Pakarinen S,Oikarinen L,Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy:a retrospective single-centre 1-year survey[J]. Europace,2010,12(1):103-108.

[17] 陈章强,洪浪,王洪,等. 永久性起搏器术后阈值升高的临床分析[J]. 江西医药,2007,42(6):518-520.

[18] 中国医师协会心律学专业委员会,中华医学会心电生理和起搏分会. 无导线起搏器临床应用中国专家共识(2022) [J]. 中华心律失常学杂志,2022,26(3):263-271.

[19] Burri H,Starck C,Auricchio A,et al. EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators:endorsed by the Heart Rhythm Society(HRS),the Asia Pacific Heart Rhythm Society(APHRS),and the Latin-American Heart Rhythm Society(LAHRS)[J]. Europace,2021,23(7):983-1008.

[20] Iwata S,Hirose A,Furui I,et al. Right ventricular perforation,pneumothorax,and a pneumatocele by a pacemaker lead:a case report[J]. JA Clin Rep,2021,7(1):1-4.

[21] Rehaman A,Ramesh A,Prajapati S,et al. Lead displacement due to tension pneumothorax following permanent pacemaker implantation[J]. J Cardiol Cases,2017,15(1):25-27.

[22] Vamos M,Erath JW,Benz AP,et al. Incidence of cardiac perforation with conventional and with leadless pacemaker systems:a systematic review and meta‐analysis[J]. J Cardiovasc Electrophysiol,2017,28(3):336-346.

[23] Hai JJ,Fang J,Tam CC,et al. Safety and feasibility of a midseptal implantation technique of a leadless pacemaker[J]. Heart Rhythm,2019,16(6):896-902.

[24] Togashi I,Sato T,Hoshida K,et al. Subclinical cardiac perforation caused by a Micra? leadless pacemaker[J]. J Arrhythm,2018,34(3):326-328.

[25] 邹彤,王志蕾,佟佳宾,等. 心脏起搏器电极脱位原因的初步探讨[J]. 中国心血管病研究,2007,5(6):411-413.

[26] 匡晓晖,张曦,高晓龙,等. 无导线起搏器临床应用单中心经验总结[J]. 中华心律失常学杂志,2021,25(1):52-55.

[27] Beurskens NEG,Tjong FVY,Dasselaar KJ,et al. Leadless pacemaker implantation after explantation of infected conventional pacemaker systems:a viable solution?[J]. Heart Rhythm,2019,16(1):66-71.

[28] Klug D,Lacroix D,Savoye C,et al. Systemic infection related to endocarditis on pacemaker leads:clinical presentation and management[J]. Circulation,1997,95(8):2098-2107.

[29] Tolosana JM,Guasch E,San Antonio R,et al. Very high pacing thresholds during long‐term follow‐up predicted by a combination of implant pacing threshold and impedance in leadless transcatheter pacemakers[J]. J Cardiovasc Electrophysiol,2020,31(4):868-874.

[30] Paniagua D,Aldrich HR,Lieberman EH,et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads[J]. Am J Cardiol,1998,82(9):1130-1132.

[31] de Cock CC,Giudici MC,Twisk JW. Comparison of the haemodynamic effects of right ventricular outflow-tract pacing with right ventricular apex pacing:a quantitative review[J]. Europace,2003,5(3):275-278.

[32] Salaun E,Tovmassian L,Simonnet B,et al. Right ventricular and tricuspid valve function in patients chronically implanted with leadless pacemakers[J]. Europace,2018,20(5):823-828.

[33] Beurskens NEG,Tjong FVY,de Bruin-Bon RHA,et al. Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up[J]. Circ Arrhythm Electrophysiol,2019,12(5):e007124.

[34] El-Chami MF,Bockstedt L,Longacre C,et al. Leadless vs. transvenous single-chamber ventricular pacing in the Micra CED study:2-year follow-up[J]. Eur Heart J,2022,43(12):1207-1215.

[35] Csa B,Skk C,Cg D,et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker:results from the MARVEL 2 study[J]. JACC Clin Electrophysiol,2020,6(1):94-106.

相似文献/References:

[1]牟秦娇 张玥 王楠.无导线起搏器在特殊人群中植入的研究进展[J].心血管病学进展,2023,(8):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]
　MOU QinjiaoZHANG YueWANG Nan.Analysis of Implantation of Leadless Pacemakers in Special Populations[J].Advances in Cardiovascular Diseases,2023,(9):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]

备注/Memo

备注/Memo:
收稿日期：2022-08-03
基金项目：云南省科技厅-科技人才与平台计划（202205AD160050）
更新日期/Last Update: 2022-10-24